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Anxiety and depression are commonly comorbid in older adults and are associated with worse physical
and mental health outcomes and poorer response to psychological and pharmacological treatments.
However, little research has examined the effectiveness of psychological programs to treat comorbid
anxiety and depression in older adults. Sixty-two community dwelling adults aged over 60 years with
comorbid anxiety and depression were randomly allocated to group cognitive behavioural therapy or a
waitlist condition and were assessed immediately following and three months after treatment. After
controlling for cognitive ability at pre-treatment, cognitive behaviour therapy resulted in signiﬁcantly
greater reductions, than waitlist, on symptoms of anxiety and depression based on a semi-structured
diagnostic interview rated by clinicians unaware of treatment condition. Signiﬁcant time by treatment
interactions were also found for self-report measures of anxiety and depression and these gains were
maintained at the three month follow up period. In contrast no signiﬁcant differences were found be-
tween groups on measures of worry and well-being. In conclusion, group cognitive behavioural therapy
is efﬁcacious in reducing comorbid anxiety and depression in geriatric populations and gains maintain
for at least three months.
 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY-NC-ND license.Objective anxiety disorder and 23% with an anxiety disorder also met criteriaEpidemiological studies show that depression and anxiety are
common disorders throughout the lifespan and that they are
typically comorbid (Beekman et al., 1998; Kessler et al., 1996).
Research indicates considerable overlap of these disorders in terms
of risk factors (Vink, Aartsen, & Schoevers, 2008), phenomenology
(Watson et al., 1995), and genetic factors, particularly for General-
ized Anxiety Disorder (GAD) and Major Depressive Disorder (MDD)
(Kendler, Gardner, Gatz, & Pedersen, 2007). Rates of comorbid
anxiety and depression in older adults are similar to those in
younger populations, with as many as 35% of primary care patients
with major depression also reporting a life time history of an
anxiety disorder and 23% reporting a current comorbid anxiety
disorder (Lenze et al., 2000). In a community sample, 47% of older
adults whomet criteria for major depression alsomet criteria for an: þ61 2 9850 8062.
V.M. Wuthrich), Ron.Rapee@
r Ltd. Open access under CC BY-NC-Nfor a comorbid major depressive disorder (Beekman et al., 2000).
In older adults, the presence of both anxiety and depression is
associated with worse outcomes than either disorder alone
including increased risk of cognitive decline and dementia (DeLuca
et al., 2005), more severe depression and increased suicide rates
(Cohen, Gilman, Houck, Szanto, & Reynolds, 2009; Lenze et al.,
2000) and a chronic course (Almeida et al., 2012). Given the high
prevalence of comorbid anxiety and depression, research indicating
that comorbidity is associated with worse outcomes, and the large
overlap in symptom proﬁles and risk factors, it is important to pay
more attention to the comorbid presentation and treatment of
these disorders in older adults.
Recent reviews of psychological treatments for depression in
older adults indicate that cognitive behavioural therapy (CBT) is as
effective as in younger adults and is superior to waitlist, care-as-
usual, placebo and other control groups, with moderate to large
effect sizes (mean d ¼ 0.72) (Cuijpers, van Straten, & Smit, 2006;
Mackin & Arean, 2005; Serfaty, Haworth, Blanchard, Buszewicz, &
King, 2009). Reviews for psychological treatment of primary anxi-
ety demonstrate the effectiveness of relaxation, supportive therapy,
and CBT in older adults (Ayers, Sorrell, Thorp, & Wetherell, 2007;
Nordhus & Pallesen, 2003). Hendriks et al. conducted a system-
atic review and meta-analysis of CBT for anxiety disorders in older
adults and concluded that CBT was superior to waitlist and activeD license.
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but only superior to waitlist conditions for worry severity
(Hendriks, Oude Voshaar, Keijsers, Hoogduin, & Van Balkom, 2008).
A recent meta-analysis of CBT for anxiety disorders in older adults
found that CBT was only marginally more effective than active
control conditions and called for approaches to increase the effec-
tiveness of CBT for anxiety in older adults (Gould, Coulson, &
Howard, 2012). They suggested that targeting comorbidity might
increase therapeutic outcomes.
Despite the high prevalence of comorbid anxiety and depres-
sion, and the particularly negative outcomes associated with this
comorbidity, there is a striking absence of studies that have focused
on the psychosocial treatment of comorbid anxiety and depression
in older adults. Sallis et al. (1983) compared the effectiveness of
three treatment conditions: relaxation training, pleasant event
scheduling and rational disputing, and a self-disclosure discussion
group on comorbid anxiety and depression in older adults. They
found that depression reduced from pre to post in all conditions
equally, while improvements in anxiety symptoms only occurred in
the placebo condition. A major limitation of this study is that the
sample size was small (n ¼ 24) and lacked the statistical power to
detect anything less than a very large difference between active
treatments. To our knowledge, no other published trial has spe-
ciﬁcally investigated the efﬁcacy of group CBT for comorbid anxiety
and depression in older adults.
The majority of studies have focused on the treatment of pri-
mary depression or anxiety and not their comorbidity, and report
that the presence of a comorbid disorder reduces the effectiveness
of treatment for the primary disorder. For example, comorbid
anxiety has been shown to delay and reduce treatment response
to both pharmacological and psychological treatments for
depression (Andreescu et al., 2007; Andreescu et al., 2009; Arnow
et al., 2007; Cohen et al., 2009; Gum, Arean, & Bostrom, 2007;
Hegel et al., 2005), and comorbid depression has been demon-
strated to reduce the effectiveness of psychological treatment for
primary anxiety in some studies (Schuurmans et al., 2009), but
has not been found to impact on effectiveness in others (Wetherell
et al., 2005).
Further, psychological treatments for primary depression have
typically failed to produce signiﬁcant reductions in comorbid
anxiety symptomatology (Dombrovski et al., 2006; Gum et al.,
2007; Serfaty et al., 2009). In contrast, psychological therapy tar-
geting geriatric anxiety typically results in simultaneous reductions
in post-treatment depression (Barrowclough et al., 2001;
Gorenstein et al., 2005; Mohlman et al., 2003; Mohlman &
Gorman, 2005; Stanley et al., 2003; Wetherell, Gatz, & Craske,
2003). However, limitations of these studies include that some
studies have excluded individuals with clinically severe depression
(Gorenstein et al., 2005; Mohlman et al., 2003; Mohlman &
Gorman, 2005), many studies have only included a small number
with comorbid depression, and none have reported post-treatment
changes in mood disorder diagnostic severity using a clinical
interview, so it is unclear whether these anxiety treatments pro-
duce diagnostically signiﬁcant change in both anxiety and
depressive disorders. Given that comorbidity reduces the effec-
tiveness of treatments targeting one disorder only (the primary
disorder) and is associated with worse long term outcomes, a
program that addresses the core features of both disorders might
be more efﬁcacious.
The aim of the current study was to conduct a randomised
controlled trial to evaluate the efﬁcacy of group CBT program tar-
geting comorbid anxiety and depression in older adults. The pri-
mary aim was to establish the program’s basic efﬁcacy by
comparing it to a comparable waitlist condition. The primary
outcome was changes in diagnostic severity for both the anxietyand depressive disorders. Secondary outcomes included changes
on self-reported anxiety, depression and life interference. We
included individuals whomet criteria or subclinical criteria for both
a mood and an anxiety disorder. We hypothesized that the CBT
conditionwould result in signiﬁcant improvements on all symptom
measures from pre to post treatment and that these gains would be
maintained at the 3 month follow up.Methods
Participants
Sixty-two community dwelling participants aged 60e84 (mean
age ¼ 67.44, SD ¼ 6.19, 22 ¼male, 40 ¼ female) were recruited via
advertisements in local newspapers. Participants attended the
Centre for Emotional Health, Macquarie University, Sydney,
Australia for assessment and treatment. All participants met DSM-
IV criteria or subclinical criteria (see below for deﬁnition) for both
an anxiety and a mood disorder, with either anxiety or mood being
the primary (most interfering) problem. In fact, the vast majority of
the sample met full DSM-IV criteria for both an anxiety disorder
and a mood disorder with either problem being primary (N ¼ 55),
with the remaining 7 participants having at least subclinical levels
of anxiety, depression or both. Exclusion criteria were: aged under
60 years, unable to read a newspaper, current self-harm, active
suicidal intent, psychosis, or bipolar disorder. All participants were
asked to refrain from engaging in additional treatment from a
therapist or making changes to their medication status during the
course of the trial.Measures
Diagnostic clinical interview
Participants completed the Anxiety Disorders Interview
Schedule for DSM-IV (ADIS: Di Nardo, Brown, & Barlow, 1994), a
semi-structured interview for diagnosing anxiety and related
disorders including mood disorders according to DSM-IV criteria
on a 0e8 severity rating scale where ratings of 4 and above are
considered of clinical severity and meet diagnostic status. This
interview was administered by ﬁve different graduate students in
clinical psychology formally trained on the ADIS and given regular
supervision to discuss diagnostic decisions. The primary disorder
was deﬁned as the one that most interfered with the person’s life.
In this study, participants with clinical severity ratings of 3 or
above for their main anxiety disorder and main mood disorder
were included in the study, as we were interested in also treating
subclinical anxiety and depression; however, 89% of the sample
met full diagnostic criteria for both an anxiety and mood disorder.
The interviews were videotaped for reliability purposes and 25%
were recoded after the study’s completion for the purpose of
reliability coding. Inter-rater reliability (k) for agreement on the
presence of a disorder in the diagnostic proﬁle was k ¼ 1.0 (100%
agreement) for mood disorder, k ¼ 1.0 (100% agreement) for
generalized anxiety disorder and k ¼ 0.81 (92% agreement) for
social phobia.
Cognitive assessment
Addenbrooke Cognitive Examination-Revised (ACE-R: Mioshi,
Dawson, Mitchell, Arnold, & Hodges, 2006), is a brief rating scale
for dementia that assesses ﬁve cognitive domains, namely atten-
tion/orientation, memory, verbal ﬂuency, language and visuospa-
tial abilities. Research indicates good sensitivity and speciﬁcity for
cut off scores of 88 (sensitivity ¼ 0.94, speciﬁcity ¼ 0.89) and 82
(sensitivity ¼ 0.84, speciﬁcity ¼ 1.0) (Mioshi et al., 2006).
Table 1
Outline of session content of Ageing Wisely program.
Session Session content Homework content
1 Introduction, psychoeducation,
myths about ageing
Read over session notes
2 Motivation to change & goal
setting, mood monitoring,
identifying presence of thoughts
in situations
Mood monitoring
3 Activity scheduling, linking
thoughts and feelings
Activity scheduling, plus
previously presented skill
4 Identifying unhelpful
thoughts, problem solving
Identifying thoughts, problem
solving, plus previously
presented skills
5 Cognitive restructuring Cognitive restructuring, plus
previously presented skills
6 Common barriers to cognitive
restructuring, using cognitive
restructuring to deal with
loneliness and low motivation
Previously presented skills
7 Review of goals, review
of skills taught so far
Previously presented skills
8 Graded exposure and
reducing avoidance
Graded exposure, plus
previously presented skills
9 Graded exposure,
assertiveness and
communication
Assertiveness practice, plus
previously presented skills
10 Sleep strategies Sleep strategies, plus previously
presented skills
11 Dealing with loss
and bereavement
Previously presented skills
12 Review goals and skills,
relapse prevention
Previously presented skills
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The following questionnaires were administered at pre-
treatment, post-treatment and 3 month follow up.
Geriatric Depression Scale (GDS: Yesavage et al., 1983), a 30 item
self-report measure of depression symptoms developed for older
adults. It has high internal consistency, reliability, sensitivity and
speciﬁcity in inpatient, outpatient and nursing home residents with
zero to moderate cognitive impairment (Jongenelis et al., 2005;
Yesavage et al., 1983). Internal consistency in this sample was
alpha ¼ .86.
The Centre for Epidemiological Studies e Depression Scale (CES-D:
Radloff, 1977), a 20 item questionnaire that assesses depression
symptoms over the past week. This questionnaire has been shown
to be reliable and valid in elders (Beekman et al., 1997; Haringsma,
Engels, Beekman, & Spinhoven, 2004). Internal consistency in this
sample was alpha ¼ .90.
The Geriatric Anxiety Inventory (GAI: Pachana et al., 2007), a 20
item measure of anxiety symptoms developed for older adults. It
has been shown to have adequate internal consistency, test-retest
reliability and concurrent validity (Pachana et al., 2007). Internal
consistency in this sample was alpha ¼ .89.
The Penn State Worry Questionnaire (PSWQ: Meyer, Miller,
Metzger, & Borkovec, 1990) is a measure of worry that has shown
adequate internal consistency and convergent validity in elderly
patients with GAD and controls (Stanley, Novy, Bourland, Beck, &
Averill, 2001). Internal consistency in this sample was alpha ¼ .84.
The Short Form e 12 version 1 Mental Health Subscale (SF12:
Ware, Kosinski, & Keller, 1996), is a general measure of mental
health status. The SF12 has been demonstrated to be reliable and
valid in older populations (Jakobsson, 2007). The internal consis-
tency in this sample was alpha ¼ .83.
Group CBT program
The Ageing Wisely group program consisted of 12  2 h sessions
conducted by the lead author and two graduate students in clinicalpsychology receiving regular supervision, with 6e8 group mem-
bers. Groups had one or two therapists with the second therapist
being largely an observer. The program included generic CBT skills
such as psycho-education, problem-solving, cognitive restructur-
ing, sleep hygiene, assertiveness training, and graded exposure
which is a core skill for treatment of anxiety, and activity sched-
uling which is a core skill for the treatment of depression. The
program was designed for older adults with skills were presented
over several sessions, including signiﬁcant repetition, large font,
and case examples of older adults focused on problems relevant to
this life stage such as worry about dementia, physical disability,
bereavement and loneliness. Due to the transdiagnostic aim of this
program, all skills were presented with examples for a depressive
type of problem and an anxious problem (mainly worry or social
evaluation concern). Similarly, graded exposure was presented
with examples for a range of anxiety problems including worry,
social anxiety and speciﬁc phobia. Cognitive restructuring was a
core component of the program and was introduced over the
course of 4 weeks, and then practiced as homework each week,
with considerable attention paid to establishing links between
thoughts and feelings. A highly structured cognitive restructuring
form was used that included the following sections: Situation,
Thoughts, Evidence Collecting and Helpful Replacement Thought.
The Evidence Collecting section included seven questions to help
identify relevant evidence including: “What would a friend say?”,
“What can my past tell me about my ability to cope here?”, “How
likely is it that it will really happen?”, and “What alternatives are
there to this situation?” See Table 1 for an outline of the session
content. The program included a detailed structured participant
and therapist workbook that included all material presented during
the sessions, and all homework exercises. Skills were taught with a
mixture of didactic teaching, group discussions and role play. There
was a large emphasis on home practice with a weekly review of
homework and homework forms for each new and previously
presented skill included in their manual each week.
Procedure
Ethical approval was obtained through theMacquarie University
Human Research Ethics Committee. After participants completed
consent forms, they completed the pre-assessment questionnaires
and provided demographic and medical information. Then they
completed the ACE-R cognitive examination and ADIS diagnostic
interview. Participants were randomly assigned, following simple
randomization procedures (computerized random numbers), to 1
of 2 treatment groups of 12 weeks duration (CBT or waitlist) in
blocks of 8 participants. At the end of the 12 weeks, participants
again completed post-treatment assessments including diagnostic
interviews (rated by clinicians unaware of condition allocation),
cognitive assessments and questionnaires. Those in the waitlist
condition were then offered group treatment and those who
completed the group program completed the assessments again
three months after the treatment ended.
Data analysis
Data analysis was conducted using SPSS (version 19, SPSS Inc.,
USA). All analyses were conducted as intent-to-treat and as such all
participants were analysed in the group to which they were rand-
omised. For partially completed self-report questionnaires, data for
the missing items were generated using the Expectation-
Maximization algorithm. This algorithm computes probabilities for
each possible completion of the missing data using the current pa-
rameters to form aweighted set that is then used to provide the new
parameter estimates (Do & Batzoglou, 2008). For participants who
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using the Multiple Imputation procedure (Schafer & Graham, 2002;
Sinharay, Stern, & Russell, 2001). Using this procedure, pre-
treatment group allocation, ADIS severity scores and questionnaire
items were used to generate 20 sets of imputed data and the pooled
data were used to predict missing scores.
Differences between groups on continuous measures (pre,
post, follow up) were examined using hierarchical mixed models
containing random intercept and random slope terms as well as
ﬁxed effects for treatment received. In order to run mixed model
analyses in SPSS for the multiple imputation pooled dataset, the
van Ginkel macro (van Ginkel, 2010) was used to calculate the F
values, standard errors, p-values, and degrees of freedom for the
group (CBT, waitlist) by time (pre, post, follow-up) interactions.
Differences between groups on diagnostic status were examined
using the chi-squared statistic to report recovery rates from pre to
post assessment. The ﬂow of participants through the study is
presented in Fig. 1.Fig. 1. Consort diagram of partiResults
The mean number of sessions attended of the twelve week
programwas 9.31 (SD ¼ 3.11). Our sample size allowed us to detect
a medium effect size (Cohen’s d > 0.4) with adequate power (90%).
Baseline measures
The groups did not differ signiﬁcantly in terms of any de-
mographic features (e.g. age, income, education), pre-assessment
ACE-R or pre-assessment questionnaires, except that the severity
of the primary problem was signiﬁcantly higher for the CBT con-
dition than the waitlist condition at pre-assessment. See Table 2 for
more details. Means on self-report questionnaires fell over (GAI,
GDS, CES-D) or close to (PSWQ) cut-offs recommended for clinical
severity, corroborating the ADIS severity ratings that the samples
were clinically impaired but not extreme. Although there was no
statistical difference between the means of the total ACE-R scorescipants through the study.
Table 2
Demographic data across conditions intent-to-treat (SD in parenthesis).
Demographic CBT (N ¼ 27) Waitlist (N ¼ 35)
Sex, % female 66.66 62.86
Age M ¼ 66.92
(SD ¼ 5.93)
M ¼ 67.80
(SD ¼ 6.53)
Highest education
level, %
Primary school 7.4 0
High school 22.22 29.41
TAFE/trade 33.33 38.24
University degree 37.04 32.35
Family income, %
>$80,000 4.00 6.25
$40,000e80,000 33.00 25
$15, 000e40,000 36.00 37.5
$0e15,000 28.00 31.25
Country of birth, %
Australia/New Zealand 59.26 62.86
Asian 7.40 5.71
Europe 25.92 20.00
Africa/Middle East 11.11 5.71
South America 0 5.70
Marital Status, %
Married/partnered 55.55 42.86
Widowed 3.70 20.00
Separated/divorced 37.04 28.57
Single, never married 3.70 8.57
Employment status, %
Full time employed 14.81 0
Part-time employed/
semi-retired
18.52 20.00
Retired 55.55 62.86
Unemployed/
unable to work
7.40 8.57
Home duties 3.70 8.57
Taking psychotropic
medication, %
22.2 20.0
ACE-R Total Score M ¼ 90.33 (SD ¼ 5.37) M ¼ 91.38 (SD ¼ 5.18)
GDS M ¼ 17.98 (SD ¼ 6.18) M ¼ 16.50 (SD ¼ 5.99)
CES-D M ¼ 26.21 (SD ¼ 8.07) M ¼ 22.66 (SD ¼ 10.96)
GAI M ¼ 11.62 (SD ¼ 4.72) M ¼ 9.49 (SD ¼ 5.43)
PSWQ M ¼ 53.75 (SD ¼ 12.39) M ¼ 49.33 (SD ¼ 13.06)
SF12 (Mental) M ¼ 43.69 (SD ¼ 9.22) M ¼ 42.15 (SD ¼ 6.69)
ADIS primary
disorder severity
M ¼ 6.37 (SD ¼ 0.653) M ¼ 5.80 (SD ¼ 1.16)*
Principal diagnoses, %
GAD 40.74 28.57
SOC 14.81 5.71
SPEC 3.70 0
PTSD 3.70 5.71
MDD 18.52 22.86
DYS 11.11 17.14
ADNOS 3.70 2.86
MDNOS 3.70 17.14
Secondary diagnoses, %
GAD 25.93 34.29
SOC 14.81 14.29
SPEC 3.70 5.71
PTSD 0 2.86
OCD 0 2.86
MDD 33.33 14.29
DYS 14.81 8.57
ADNOS 7.40 2.86
MDNOS 0 5.71
Note: Based on original dataset, M ¼ Mean, SD ¼ Standard Deviation, ACE-
R ¼ Addenbrooke Cognitive Examination Revised, ADIS ¼ Anxiety Disorder Inter-
view Schedule, GDS ¼ Geriatric Depression Scale, CES-D ¼ Centre for Epidemio-
logical Studies Depression Scale, GAI ¼ Geriatric Anxiety Inventory, PSWQ ¼ Penn
State Worry Questionnaire, SF12 ¼ Short Form 12, GAD ¼ Generalized anxiety
disorder; SOC ¼ Social Phobia; SPEC ¼ Speciﬁc phobia; PTSD ¼ Post traumatic stress
disorder; OCD ¼ Obsessive Compulsive Disorder, MDD ¼ Major Depressive Disor-
der; DYS ¼ Dysthymia; ADNOS ¼ Anxiety Disorder Not Otherwise Speciﬁed;
MDNOS ¼ Mood Disorder Not Otherwise Speciﬁed, *F (1,61) ¼ 5.32, p ¼ 0.03 (all
other differences between groups were non-signiﬁcant, ANOVAs p > .05).
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cognitive ability varied (range 73e98) and pre-treatment cognition
may be important for the ability to learn and implement CBT
(Johnco, Wuthrich, & Rapee, 2013), pre-assessment cognition was
statistically controlled in all further analyses. Three participants
had ACE-R scores <82 and therefore had likely dementia.
Diagnostic severity across time and condition
Using mixed model analyses on the pooled data, the interaction
between time (pre, post) and group (CBT, waitlist) for the clinician
rated severity of the primary problem was signiﬁcant,
F(1,47.95) ¼ 17.36, p < .001, demonstrating a signiﬁcant improve-
ment with treatment compared to waitlist. Estimated marginal
means, standard errors and within group effect sizes for all mixed
model analyses are presented in Table 3.
To compare the efﬁcacy of the CBT program in reducing anxiety
and depression separately, we coded the primary problem as either
anxiety or mood. Mixed model analysis failed to demonstrate a
signiﬁcant interaction between time (pre, post), group
(CBT, waitlist), and primary problem type (anxiety, mood), F(1,
45.38) ¼ .632, p ¼ .431. This indicated that the CBT group program
did not statistically differ in its efﬁcacy in reducing primary anxiety
and primary mood problems.
Questionnaire measures across time and condition
Mixed model analyses indicated signiﬁcant time by group in-
teractions on the GDS, F(1, 50.88) ¼ 8.86, p ¼ .004, CES-D, F(1,
53.23)¼ 7.90, p¼ .007, and the GAI, F(1, 55.65)¼ 7.40, p¼ .009.1 In all
cases self-reported anxiety and depression symptoms reduced signif-
icantlymore in theCBTcondition thanwaitlist. Incontrast, thegroupby
time interaction was not signiﬁcant for the PSWQ, F(1, 54.95) ¼ 0.57,
p¼ .452, or the SF12 Mental scale, F(1,51.39)¼ .000, p ¼ .988.
Evaluation of treatment maintenance
Mixed model analyses were used to determine whether the
beneﬁts from treatment were retained at the follow up period for
the CBT condition controlling for ACER scores at pre-assessment
(there was no follow up data for the waitlist condition as partici-
pants received CBT immediately after the post assessment). For the
clinician-rated severity of the primary problem there was a sig-
niﬁcant main effect of time, F(2, 49.53) ¼ 35.23, p < .001, where
severity of the primary problemwas signiﬁcantly reduced from pre
to post treatment, t(42.12) ¼ 8.00, p < .001, but not from post to
follow-up, t(33.60) ¼ 1.23, p ¼ .22. See Table 4. To check whether
the efﬁcacy of the CBT program differed for anxiety symptoms
compared to depressive symptoms over time, we examined the
interaction between time (pre, post, follow up) and primary
problem type (anxiety, mood) and found a non-signiﬁcant inter-
action, F(2, 48.12) ¼ .293, p ¼ .75, indicating that reductions in
symptoms over time were not statistically different for symptoms
of depression or anxiety.
For the majority of self-report measures, the mixed model
analysis indicated a signiﬁcant change over time that was main-
tained at follow-up: GDS, F(2, 49.31) ¼ 21.04, p < .001, pre to post
treatment reduction, t(46.39) ¼ 5.49, p < .001, post to follow up,
t(44.71) ¼ .29, p ¼ .77, CES-D, F(2, 49.48) ¼ 34.52, p < .001, pre to
post treatment reduction, t(47.38) ¼ 7.29, p < .001, post to follow
up, t(45.96) ¼ .10, p ¼ .93, GAI, F(2, 49.79) ¼ 9.46, p < .001, pre to1 A Bonferroni adjustment was made to account for multiple comparisons,
alpha ¼ .01 (.05/5).
Table 3
Estimated marginal means, standard errors & effect sizes for diagnostic severity over time.
Parameter CBT Waitlist
Mean Standard error Effect size* ES 95% CI Mean Standard error Effect size* ES 95% CI
Severity Primary Problem
Pre-treatment 6.33 .25 1.46 0.74, 2.18 5.81 .21 0.49 0.05, 1.03
Post-treatment 3.46 .29 5.15 .24
Severity Primary Mood Problem
Pre-treatment 6.53 .44 2.13 0.71, 3.55 5.61 .29 0.49 0.19, 1.17
Post-treatment 3.00 .52 4.93 .31
Severity Primary Anxiety Problem
Pre-treatment 6.25 .29 1.20 0.36, 2.04 6.05 .31 0.42 0.47, 1.31
Post-treatment 3.71 .34 5.46 .38
Geriatric Depression Scale
Pre-treatment 18.14 1.28 0.98 0.30, 1.65 16.35 1.10 0.15 0.39, 0.69
Post-treatment 9.21 1.44 14.38 1.23
Centre for Epidemiological Studies-Depression
Pre-treatment 26.37 1.94 1.41 0.72, 2.10 22.61 1.70 0.04 0.51, 0.59
Post-treatment 13.34 2.18 21.15 1.90
Geriatric Anxiety Inventory
Pre-treatment 11.59 1.10 0.95 0.28, 1.62 9.48 .95 0.23 0.32, 0.78
Post-treatment 5.84 1.20 8.33 1.04
Penn State Worry Questionnaire
Pre-treatment 53.62 2.52 0.50 0.13, 0.87 49.27 2.20 0.32 0.23, 0.87
Post-treatment 46.54 2.80 47.24 2.41
Short Form-12 (Mental)
Pre-treatment 37.09 2.01 0.86 0.20, 1.52 38.45 1.73 0.41 0.15,0.97
Post-treatment 47.79 2.26 43.56 1.97
Note. Calculations are based on the original dataset. *Effect size expressed as Cohen’s d, on the basis of preepost treatment change within conditions using pooled baseline
standard deviations, Cohen’s d ¼ M1  M2/SD pooled. ES 95% CI ¼ Effect size with 95% conﬁdence intervals. Conﬁdence intervals for effect sizes were computed using pro-
cedures delineated by Odgaard and Fowler (2010).
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t(47.18) ¼ .72, p ¼ .47, and PSWQ, F(2, 49.76) ¼ 5.93, p ¼ .005, pre
to post treatment, t(47.56) ¼ 3.21, p < .005, post to follow up,
t(47.36) ¼ .55, p ¼ .59. The improvement over time for the SF12
Mental scale was not signiﬁcant, F(2, 53.14) ¼ 4.16, p ¼ .02. 2Table 4
Estimated marginal means and standard errors for treatment maintenance.Recovery rates
We calculated recovery rates in two different ways. First, when
clinical status was deﬁned as a clinician-rated severity score of 3 or
greater on the ADIS (capturing subclinical problems), the treatment
condition resulted in signiﬁcantly higher recovery rates for the pri-
mary problem (42% recovery rate) compared to thewaitlist condition
(7.4% recovery rate) at post-treatment, c2(1, N ¼ 46) ¼ 7.89, p < .01.
Second, when we based recovery rates on the presence of a full
clinical anxiety ormood disorder (reﬂected by a severity score of 4 or
greater on the ADIS), the analysis revealed that the treatment con-
dition resulted in a signiﬁcantly higher recovery rate on the primary
disorder at post-treatment, c2 (1, N ¼ 46) ¼ 9.48, p < .005, for the
treatment condition (53% recovery rate) compared to the waitlist
condition (11% recovery rate), and this recoverywasmaintained, and
increased (67% recovery rate) at three month follow up.Variables Estimated marginal means with standard
error in brackets
Pre Post Follow-up
Clinician Rated Severity
Primary Disorders
6.35 (.26) 3.46 (.31) 2.84 (.36)
Clinician Rated Mean Severity
All Anxiety Disorders
6.22 (.30) 3.68 (.35) 2.52 (.43)
Clinician Rated Mean Severity
All Mood Disorders
6.62 (.49) 2.99 (.60) 3.33 (.65)
Geriatric Depression Scale 18.15 (1.40) 9.04 (1.58) 9.85 (1.58)
Centre for Epidemiological
Studies-Depression
26.48 (1.52) 13.00 (1.77) 13.50 (1.77)Reliable change
Weanalysed the extent towhich change on themain outcomewas
statistically reliable and clinically relevant by calculating the Reliable
Change Index according to Evans, Margison, and Barkham (1998)
which is based on the original formula by Jacobson and Truax (1991).
The reliable change was calculated with the following formula where
SD1 is the standard deviation of the baseline observation and r is the
reliability of the measure, SEdiff ¼ SD1O2O1  r. For this purpose, the2 A Bonferroni adjustment was made to account for multiple comparisons,
alpha ¼ .01 (.05/5).standard deviation and reliability score were taken from the current
sample. Accordingly, 74%of theparticipants in theCBTgroupshoweda
reliable improvement from baseline to post-treatment, increasing to
86% at 3-month follow-up. Reliable change for the waitlist condition
from baseline to post-treatment was 23%. There was no reliable
worsening of severity in the two groups. Chi-square tests were calcu-
lated showing that the difference between groups from pre to post-
treatment was signiﬁcant (1, N ¼ 45) ¼ 11.39, p < .005. Reliable
change was also detected for the CBT group at post-treatment
compared to the waitlist group on the following scales: GAI ¼ 47%
(compared to 15% waitlist), (1, N ¼ 62) ¼ 5.47, p < .05; GDS ¼ 44%
(compared to 0.03%waitlist), (1,N¼ 62)¼ 15.91, p< .001; CESD¼ 41%
(compared to 0.06% inwaitlist), (1, N ¼ 62) ¼ 11.28, p < .005.
Discussion
This study reported on the efﬁcacy of a group CBT program for
older adults with comorbid anxiety and depression that assessed
changes in diagnostic severity of anxiety and mood symptoms atGeriatric Anxiety Inventory 11.53 (1.18) 5.81 (1.35) 6.48 (1.35)
Penn State Worry Questionnaire 53.53 (2.23) 47.11 (2.58) 44.54 (2.58)
Short Form e 12 (Mental Scale) 37.13 (2.09) 48.23 (2.39) 47.43 (2.39)
Note: Based on original dataset.
V.M. Wuthrich, R.M. Rapee / Behaviour Research and Therapy 51 (2013) 779e786 785pre-treatment, post-treatment, and follow up periods. Compared to
waitlist, older adults receiving treatment demonstrated signiﬁcant
improvements according to clinician reported severity of primary
anxiety and mood problems. Importantly, the degree of improve-
ment in primary anxiety and primary mood problems was similar
indicating that the program successfully targeted both disorders. In
addition, we found signiﬁcant improvements in self-reported rat-
ings of anxiety and depression following CBT but not waitlist. All of
these changes were maintained three months following the end of
treatment. These improvements resulted in recovery rates of the
primary clinical problem of 52% in the treatment group compared
to 11% of the waitlist group that were maintained three months
later. Further, signiﬁcant reliable change was shown by 74% of CBT
participants compared to 23% of waitlist participants on clinician
rated severity of their main problem and by 40e50% of CBT par-
ticipants compared with <1%e15% of participants on waitlist on
self report measures.
Despite these improvements, we failed to ﬁnd a signiﬁcant
group by time interaction on the PSWQ and the SF12 Mental scale.
The relatively minimal change on the PSWQ relative to strong
changes seen on other measures is interesting and in contrast to
most other studies on GAD in older adults. One possible conclusion
is that although the treatment package focused heavily on cognitive
restructuring skills it did not satisfactorily target symptoms of
worry. Given that a large portion of our sample were diagnosed
with GAD, post-hoc analyses were conducted to compare changes
in clinician-rated severity between those with primary GAD and
those with other primary anxiety or mood disorders. The results
showed a non-signiﬁcant group by time interaction, F(2,
47.09) ¼ 0.10, p ¼ .908, and a non-signiﬁcant time effect,
F(2,26.32) ¼ 0.65, p ¼ 0.53. Because these non-signiﬁcant com-
parisons may be affected by a lack of power, we also examined
whether there was a signiﬁcant main effect of time on GAD severity
for those treated with CBT, and found a signiﬁcant effect
F(2,13.81) ¼ 9.14, p < .005. These results suggest that this program
was effective for individuals with GAD, but for some reason the
PSWQ did not detect these improvements when examined for all
individuals in the trial. The fact that the PSWQ has been shown to
have only moderate test-retest reliability (Hopko et al., 2003;
Stanley et al., 2001) and a different factor structure in older sam-
ples compared to younger samples (Knight, McMahon, Skeaff, &
Green, 2008) might also contribute to these ﬁndings.
The failure to ﬁnd signiﬁcant change on the SF12 Mental scale
with treatmentmight reﬂect the broad nature of this scale and a life
interference measure more targeted at impairment associated with
anxiety and depression in older adults might have identiﬁed
stronger differences. Although there was sufﬁcient power in this
study to detect medium effects, changes on the PSWQ and SF12
may reﬂect smaller effects that weren’t detected in this sample.
Further research is needed with larger sample sizes.
It is important to note that the CBT program showed similar
effects in reducing symptoms of both anxiety and depression. Thus,
in line with our aims, it appears that the program was able to
adequately target both disorders in this population. Given high
rates of comorbidity, the vast overlap in symptoms, and previous
ﬁndings that comorbidity is generally associated with worse
treatment outcomes in single disorder treatment studies, research
should continue to focus on treating these disorders together. This
result is in line with recent work that has demonstrated that CBT
can be used in older adults with subclinical levels of anxiety and
depression in a preventative role, with results lasting at least two
years (van’t Veer-Tazelaar et al., 2011; van’t Veer-Tazelaar et al.,
2009). The direction is also consistent with recent moves among
programs for younger adults that aim to target broader emotional
distress rather than individual disorders (Farchione et al., 2012).Limitations of the study include that treatmentwas compared to
a waitlist control and not an active intervention that controlled for
other nonspeciﬁc therapy factors. Socializing with others and being
heard by an empathetic therapist are important nonspeciﬁc ther-
apeutic factors that are present in a group therapy format and may
have accounted for some of the treatment effects. Therefore future
research needs to compare group CBT with a placebo group con-
dition that speciﬁcally controls for potential nonspeciﬁc therapy
factors or with other group based psychological treatments in order
to determine whether the speciﬁc components associated with the
CBT program are speciﬁcally responsible for the efﬁcacy of the
intervention. Further, the power achieved in this study was prob-
ably too low to detect small differences in treatment efﬁcacy for
worry severity and life interference, or to detect differences in the
effectiveness of the program for anxiety versus mood symptoms.
The study also had a relatively short follow up period of 3 months.
Previous research has shown maintenance of treatment gains for
speciﬁc disorders among older adults up to 12 months (Stanley
et al., 2003) so it is unlikely that the effects reported here would
dissipate with time, but demonstration of this maintenance within
a comorbid populationwould be valuable. Finally, this study lacked
formal treatment adherence and therapist competence measures.
Instead these issues were monitored by weekly supervision ses-
sions with study authors, but should be included in future studies.
Overall this study meets a need to develop an efﬁcacious
transdiagnostic psychological treatment program to tackle the
problem of comorbid anxiety and depression in older adults.
Tackling both disorders at once is likely to be cost-effective and
produce superior outcomes to treatments that focus on the primary
disorder only. Given the negative consequences of anxiety and
depression in older adults, interventions such as this may help to
reduce the risk of these negative outcomes and produce lasting
beneﬁts for older individuals.Acknowledgements
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